ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,375.86
      1.67%
      US Tech 100
      18,102.00
      -0.44%
      Dow Jones
      39,606.57
      1.07%
      Brent Oil
      65.835
      0.74%
      Bitcoin
      92,462.60
      -1.36%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Akebia Therapeutics Inc (AKBA) Quote

      Akebia Therapeutics Inc

      Akebia Therapeutics Inc (AKBA)

      NASDAQ
      2.16
      0.02
      (0.93%)
      Closed April 23 4:00PM
      Delayed by 15 minutes
      2.16
      0.00
      ( 0.00% )
      Pre Market: 4:00AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      2.16
      Bid
      2.12
      Ask
      2.26
      Volume
      2
      0.00 Day's Range 0.00
      0.80 52 Week Range 2.89
      Market Cap
      510.259M
      Previous Close
      2.16
      Open
      -
      Last Trade
      2
      @
      2.16
      Last Trade Time
      05:36:32
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      4,043,717
      Shares Outstanding
      236,231,057
      Dividend Yield
      -
      PE Ratio
      -7.35
      Earnings Per Share (EPS)
      -0.29
      Revenue
      160.18M
      Net Profit
      -69.41M

      About Akebia Therapeutics Inc

      Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment... Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.akebia.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Akebia Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AKBA. The last closing price for Akebia Therapeutics was $2.16. Over the last year, Akebia Therapeutics shares have traded in a share price range of $ 0.80 to $ 2.89.

      Akebia Therapeutics currently has 236,231,057 shares outstanding. The market capitalization of Akebia Therapeutics is $510.26 million. Akebia Therapeutics has a price to earnings ratio (PE ratio) of -7.35.

      Ask ADVFN Intelligence (AI)

      AKBA Latest News

      More News

      Form 8-K - Current report
      Edgar (US Regulatory)
      March 20 2025
      AKBA (0.93%)

      Form 424B5 - Prospectus [Rule 424(b)(5)]
      Edgar (US Regulatory)
      March 20 2025
      AKBA (0.93%)

      Form 424B5 - Prospectus [Rule 424(b)(5)]
      Edgar (US Regulatory)
      March 19 2025
      AKBA (0.93%)

      Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
      Edgar (US Regulatory)
      March 13 2025
      AKBA (0.93%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.2613.68421052631.92.271.929618862.09784977CS
      40.2513.08900523561.912.271.5242349951.83275617CS
      12-0.14-6.086956521742.32.891.5240437171.98815612CS
      260.56351.62.891.5231397111.96707664CS
      520.7957.66423357661.372.890.826890881.66225816CS
      1561.6887358.3068109480.47132.890.24131530761.04784854CS
      260-5.15-70.45143638857.3113.780.24138001712.10058744CS

      AKBA - Frequently Asked Questions (FAQ)

      What is the current Akebia Therapeutics share price?
      The current share price of Akebia Therapeutics is $ 2.16
      How many Akebia Therapeutics shares are in issue?
      Akebia Therapeutics has 236,231,057 shares in issue
      What is the market cap of Akebia Therapeutics?
      The market capitalisation of Akebia Therapeutics is USD 510.26M
      What is the 1 year trading range for Akebia Therapeutics share price?
      Akebia Therapeutics has traded in the range of $ 0.80 to $ 2.89 during the past year
      What is the PE ratio of Akebia Therapeutics?
      The price to earnings ratio of Akebia Therapeutics is -7.35
      What is the cash to sales ratio of Akebia Therapeutics?
      The cash to sales ratio of Akebia Therapeutics is 3.19
      What is the reporting currency for Akebia Therapeutics?
      Akebia Therapeutics reports financial results in USD
      What is the latest annual turnover for Akebia Therapeutics?
      The latest annual turnover of Akebia Therapeutics is USD 160.18M
      What is the latest annual profit for Akebia Therapeutics?
      The latest annual profit of Akebia Therapeutics is USD -69.41M
      What is the registered address of Akebia Therapeutics?
      The registered address for Akebia Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
      What is the Akebia Therapeutics website address?
      The website address for Akebia Therapeutics is www.akebia.com
      Which industry sector does Akebia Therapeutics operate in?
      Akebia Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CNEYCN Energy Group Inc
      $ 0.2279
      (79.31%)
      		61.68M
      PETWag Group Company
      $ 0.1966
      (78.24%)
      		41.34M
      LCUTLifetime Brands Inc
      $ 5.89
      (58.33%)
      		4
      NTHINeOne Technologies Holdings Inc
      $ 9.30
      (58.16%)
      		4
      LDTCLeddarTech Holdings Inc
      $ 0.5899
      (41.56%)
      		2
      GNLNGreenlane Holdings Inc
      $ 0.0191
      (-92.22%)
      		26.06M
      TBLDThomburg Income Builder Opportunities Trust
      $ 7.21
      (-58.85%)
      		12
      JAMFJamf Holding Corporation
      $ 6.11
      (-44.00%)
      		22
      FLNTFluent Inc
      $ 1.51
      (-38.24%)
      		1
      RAASMI 3Fourteen REAL Asset Allocation ETF
      $ 15.01
      (-36.29%)
      		2
      CNEYCN Energy Group Inc
      $ 0.2258
      (77.66%)
      		61.68M
      PETWag Group Company
      $ 0.1966
      (78.24%)
      		41.34M
      GNLNGreenlane Holdings Inc
      $ 0.0191
      (-92.22%)
      		26.06M
      DMNDamon Inc
      $ 0.0036
      (-12.20%)
      		22.14M
      TWGTop Wealth Group Holding Ltd
      $ 0.155
      (2.92%)
      		13.12M

      AKBA Discussion

      View Posts
      microchips microchips 1 week ago
      At $2 this one is just warming up for the long haul to multiples higher. The key is the 2025 sales of Vafseo and then the expansion of use to non-dialysis patients into subsequent years.
      👍️0
      makinezmoney makinezmoney 1 month ago
      $AKBA: Nuttssssssssssssssssssssss


      Whats the deal here...... now $2.80

      Someone wanna shed some light on this ???

      GO $AKBA
      👍️0
      TrendTrade2016 TrendTrade2016 1 month ago
      ALKB FDA APPROVED BIO BEAST
      👍️0
      TrendTrade2016 TrendTrade2016 1 month ago
      AKBA READY FOR 3 BUCKS
      👍️0
      TrendTrade2016 TrendTrade2016 1 month ago
      AKBA WEEKLY BREAK OUT
      👍️0
      glenn1919 glenn1919 1 month ago
      AKBA...............................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
      👍️0
      TrendTrade2016 TrendTrade2016 1 month ago
      AKBA BREAKING above 2.00 bio beast setting up
      👍️0
      microchips microchips 1 month ago
      Wow. After that update somebody finally got this one figured out. It's going 5 to 10 dollars this year. Then, depending on the progress and outcome of the next trial start again August of 2025, we're talking 20 - 30 Dollars or more in 2026 and 27.
      👍️0
      Monksdream Monksdream 2 months ago
      AKBA under $2
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      AKBA test that 2.50 from a year ago
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      AKBA breaking out
      👍️0
      glenn1919 glenn1919 3 months ago
      AKBA....................................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 3 months ago
      akba........................https://stockcharts.com/h-sc/ui?s=akba&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 3 months ago
      AKBA.............................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 3 months ago
      AKBA.................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 5 months ago
      AKBA.....................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      AKBA BIO BEAST INTO FDA
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      AKBA BEASTING LONG...FDA APPROVED DRUG COMES TO MARKET IN JAN
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      AKBA BUILDING 1.79 BREAK IS COMING
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      AKBA GAPPING AND READY FOR 1.79
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      AKBA BACK IN PLAY UNTIL JAN 2025...FDA COMING
      👍️0
      glenn1919 glenn1919 8 months ago
      AKBA.....................................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 8 months ago
      AKBA................................https://stockcharts.com/h-sc/ui?s=ARKB&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 8 months ago
      AKBA......................................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 9 months ago
      AKBA...........................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
      👍️0
      Krspecialized Krspecialized 9 months ago
      I believe the current news releases may have answered your question. GLTA
      👍️0
      Toofuzzy Toofuzzy 11 months ago
      Why do you say we have a gold mine here ?

      Toofuzzy
      👍️0
      Krspecialized Krspecialized 11 months ago
      There's no doubt we have a gold mine here, and at some point it will be load up time. Figuring out when is the big question!
      👍️0
      eyeownu eyeownu 11 months ago
      SCARY MOVIE
      👍️0
      eyeownu eyeownu 11 months ago
      https://journey.ct.events/view/a825b116-e5ee-4e76-ad8d-2e9e9116aa21 tomorrows web cast
      👍️0
      eyeownu eyeownu 11 months ago
      added 2k@ 1.11
      👍️ 1
      glenn1919 glenn1919 12 months ago
      AKBA................................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 1 year ago
      AKBA under $2

      👍️0
      eyeownu eyeownu 1 year ago
      ask is stacked! someone needs to slap it.
      👍️0
      eyeownu eyeownu 1 year ago
      $AKBA RELOAD
      👍️0
      Firestorm22 Firestorm22 1 year ago
      Starting to remind me of a “pump and dump” stock. Spikes up but always comes back down to where it started.
      👍️0
      Firestorm22 Firestorm22 1 year ago
      Starting to remind me of a “pump and dump” stock. Spikes up but always comes back down to where it started.
      👍️0
      ErnieBilco ErnieBilco 1 year ago
      I'm in at 33 cents so I'm not going anywhere, just gonna let it ride wherever it goes
      👍️ 1
      Firestorm22 Firestorm22 1 year ago
      Thanks, I’m hanging onto it . With actual revenues of 40-60 mill the last 5 quarters, one would think this stock price should rise. I wouldn’t mind seeing them bought out.
      👍️ 1
      ErnieBilco ErnieBilco 1 year ago
      Classic sell the news. Probable offering coming next week to dilute on the good news.
      👍️0
      Firestorm22 Firestorm22 1 year ago
      Something just isnt right here. How do you get FDA approval for a drug and your stock price tank? Is there some bads news getting ready to come out on this company??
      👍️0
      Krspecialized Krspecialized 1 year ago
      Long solid position here!
      👍️0
      Limey42 Limey42 1 year ago
      Long term play. Congrats all!
      👍️ 1
      dugie100 dugie100 1 year ago
      Something didn’t look good , I guess!
      👍️0
      TrendTrade2016 TrendTrade2016 1 year ago
      AKBA should see 3 bucks
      👍️0
      TrendTrade2016 TrendTrade2016 1 year ago
      AKBA...FDA EXPLOSION ...WE LOADED THIS BEAUTY....KOCKED AND LOADED!!!!
      👍️0
      glenn1919 glenn1919 1 year ago
      AKBA...................................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 1 year ago
      AKBA new 52 hi
      👍️0
      eyeownu eyeownu 1 year ago
      $AKBA looking good damn! she fine.
      👍️ 1
      glenn1919 glenn1919 1 year ago
      AKBA.................................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
      👍️0

      Your Recent History

      NASDAQ
      AKBA
      Akebia Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads